Advanced search
Publication Cover
Expert Review of Hematology Volume 10, 2017 - Issue 3
Submit an article Journal homepage
1,575
Views
17
CrossRef citations to date
0
Altmetric
Review

Triplet combinations in relapsed/refractory myeloma: update on recent phase 3 trials

Jean-Samuel BoudreaultHematology Department, University Hospital Hôtel-Dieu, Nantes, FranceView further author information
,
Cyrille TouzeauHematology Department, University Hospital Hôtel-Dieu, Nantes, FranceView further author information
&
Philippe MoreauHematology Department, University Hospital Hôtel-Dieu, Nantes, FranceCorrespondence[email protected]
View further author information
Pages 207-215 | Received 20 Sep 2016, Accepted 19 Jan 2017, Published online: 09 Feb 2017

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Thomas A. Guerrero-Garcia, Sara Gandolfi, Jacob P. Laubach, Teru Hideshima, Dharminder Chauhan, Constantine Mitsiades, Kenneth C. Anderson & Paul G. Richardson. (2018) The power of proteasome inhibition in multiple myeloma. Expert Review of Proteomics 15:12, pages 1033-1052.
Read now

Articles from other publishers (16)

M. Macro, C. Hulin, L. Vincent, A. Charvet-Rumpler, L. Benboubker, C. Calmettes, A.-M. Stoppa, K. Laribi, L. Clement-Filliatre, H. Zerazhi, F. Honeyman, V. Richez, F. Maloisel, L. Karlin, J. Barrak, C. Chouaid & X. Leleu. (2023) Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study. Annals of Hematology 102:8, pages 2137-2151.
Crossref
Zsolt Matula, Ferenc Uher, István Vályi-Nagy & Gábor Mikala. (2023) The Effect of Belantamab Mafodotin on Primary Myeloma–Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal Cells. International Journal of Molecular Sciences 24:6, pages 5303.
Crossref
Mariaserena Giliberto, Deepak B. Thimiri Govinda Raj, Andrea Cremaschi, Sigrid S. Skånland, Alexandra Gade, Geir E. Tjønnfjord, Fredrik Schjesvold, Ludvig A. Munthe & Kjetil Taskén. (2022) Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically . Molecular Oncology 16:6, pages 1241-1258.
Crossref
Hang Quach, Ajay Nooka, Olga Samoylova, Christopher P. Venner, Kihyun Kim, Thierry Facon, Andrew Spencer, Saad Z. Usmani, Sebastian Grosicki, Kenshi Suzuki, Sosana Delimpasi, Katja Weisel, Mihaela Obreja, Anita Zahlten‐Kumeli & Maria‐Victoria Mateos. (2021) Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy. British Journal of Haematology 194:4, pages 784-788.
Crossref
Matthew R. Liebers. 2020. Detection Methods in Precision Medicine. Detection Methods in Precision Medicine 345 362 .
Helmi Alfarra, Jackson Weir, Stacy Grieve & Tony Reiman. (2020) Targeting NK Cell Inhibitory Receptors for Precision Multiple Myeloma Immunotherapy. Frontiers in Immunology 11.
Crossref
Robert M. Rifkin, Jill A. Bell, Pronabesh DasMahapatra, Michael Hoole, Maria Lowe, Chris Curran, Scott Campbell, Peijie Hou & Dorothy Romanus. (2019) Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma. PharmacoEconomics - Open 4:3, pages 473-483.
Crossref
Giuseppe Di Lernia, Patrizia Leone, Antonio Giovanni Solimando, Alessio Buonavoglia, Ilaria Saltarella, Roberto Ria, Paolo Ditonno, Nicola Silvestris, Lucilla Crudele, Angelo Vacca & Vito Racanelli. (2020) Bortezomib Treatment Modulates Autophagy in Multiple Myeloma. Journal of Clinical Medicine 9:2, pages 552.
Crossref
Ajai Chari, Dorothy Romanus, Pronabesh DasMahapatra, Michael Hoole, Maria Lowe, Chris Curran, Scott Campbell & Jill A. Bell. (2019) Patient-Reported Factors in Treatment Satisfaction in Patients with Relapsed/Refractory Multiple Myeloma (RRMM). The Oncologist 24:11, pages 1479-1487.
Crossref
R. Kurzrock, L.A. Gurski, R.W. Carlson, D.S. Ettinger, S.M. Horwitz, S.K. Kumar, L. Million, M. von Mehren & A.B. BensonIIIIII. (2019) Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals. Annals of Oncology 30:10, pages 1647-1652.
Crossref
M. Offidani, M. Boccadoro, F. Di Raimondo, M. T. Petrucci, P. Tosi & M. Cavo. (2019) Expert Panel Consensus Statement for Proper Evaluation of First Relapse in Multiple Myeloma. Current Hematologic Malignancy Reports 14:3, pages 187-196.
Crossref
Chia-Hung Yen & Hui-Hua Hsiao. (2018) NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma. International Journal of Molecular Sciences 19:11, pages 3503.
Crossref
Massimo Offidani & Laura Corvatta. (2018) A review discussing elotuzumab and its use in the second-line plus treatment of multiple myeloma. Future Oncology 14:4, pages 319-329.
Crossref
Jacob P. Laubach, Philippe Moreau, Meletios A. Dimopoulos & Paul G. Richardson. 2018. Multiple Myeloma and Other Plasma Cell Neoplasms. Multiple Myeloma and Other Plasma Cell Neoplasms 73 96 .
Sara Gandolfi, Jacob P. Laubach, Teru Hideshima, Dharminder Chauhan, Kenneth C. Anderson & Paul G. Richardson. (2017) The proteasome and proteasome inhibitors in multiple myeloma. Cancer and Metastasis Reviews 36:4, pages 561-584.
Crossref
P Moreau. (2017) New drugs in myeloma: beware of phase I trial results, beware of cost and demand for new trials. Leukemia 31:9, pages 1843-1844.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.